{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:25:29Z","timestamp":1777649129528,"version":"3.51.4"},"reference-count":85,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.04.042","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T07:46:40Z","timestamp":1588837600000},"page":"4298-4308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dissociation of TRIF bias and adjuvanticity"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-2103","authenticated-orcid":false,"given":"Katharina","family":"Richard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren J.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin M.","family":"Harberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-5146","authenticated-orcid":false,"given":"Archana","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari Ann","family":"Shirey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1384-0669","authenticated-orcid":false,"given":"Alexandra","family":"Vlk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anup","family":"Mahurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreeram","family":"Nallar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn D.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie N.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.04.042_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0010","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1286-4579(02)01613-1","article-title":"Toll receptors, CD14, and macrophage activation and deactivation by LPS","volume":"4","author":"Dobrovolskaia","year":"2002","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2020.04.042_b0015","doi-asserted-by":"crossref","unstructured":"Johnson AG, Gaines S, Landy M. Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide. J Exp Med. 1956;103:225-46.","DOI":"10.1084\/jem.103.2.225"},{"key":"10.1016\/j.vaccine.2020.04.042_b0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1753425916644675","article-title":"LPS stimulates IgM production in vivo without help from non-B cells","volume":"22","author":"Lu","year":"2016","journal-title":"Innate Immun"},{"key":"10.1016\/j.vaccine.2020.04.042_b0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3181\/00379727-184-42466","article-title":"Immunogenicity and adjuvanticity of lipopolysaccharide from Legionella pneumophila","volume":"184","author":"Friedman","year":"1987","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2020.04.042_b0030","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.4049\/jimmunol.179.10.6524","article-title":"The lipopolysaccharide adjuvant effect on T cells relies on nonoverlapping contributions from the MyD88 pathway and CD11c+ cells","volume":"179","author":"McAleer","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0035","series-title":"Immunomodulation by bacteria and their products","first-page":"1","article-title":"Microbial adjuvants and immune responsiveness","author":"Johnson","year":"1981"},{"key":"10.1016\/j.vaccine.2020.04.042_b0040","doi-asserted-by":"crossref","unstructured":"Morrison DC, Ryan JL. Bacterial endotoxins and host immune responses. In: Dixon FJ, Kunkel HG, editors. Advances in immunology: Academic Press; 1980. p. 293-450.","DOI":"10.1016\/S0065-2776(08)60802-0"},{"key":"10.1016\/j.vaccine.2020.04.042_b0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-12-404717-4.00003-2","article-title":"Immunopharmacology of lipid A mimetics","volume":"66","author":"Bowen","year":"2013","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0050","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cell.2007.08.002","article-title":"Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran","volume":"130","author":"Kim","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2020.04.042_b0055","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.04.042_b0060","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31377","article-title":"Activation of Toll-like receptors nucleates assembly of the MyDDosome signaling hub","volume":"7","author":"Latty","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2020.04.042_b0065","doi-asserted-by":"crossref","first-page":"8391","DOI":"10.1073\/pnas.1424980112","article-title":"CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance","volume":"112","author":"Rajaiah","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.04.042_b0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/JLB.MR0318-096R","article-title":"Understanding early TLR signaling through the Myddosome","volume":"105","author":"Balka","year":"2019","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ni1569","article-title":"TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta","volume":"9","author":"Kagan","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0080","doi-asserted-by":"crossref","DOI":"10.1002\/JLB.3MIR1218-483RR","article-title":"Below the surface: The inner lives of TLR4 and TLR9","author":"Marongiu","year":"2019","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0085","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"Mata-Haro","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.04.042_b0090","doi-asserted-by":"crossref","first-page":"ra108","DOI":"10.1126\/scisignal.2005442","article-title":"Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF","volume":"7","author":"Kolb","year":"2014","journal-title":"Sci Signal"},{"key":"10.1016\/j.vaccine.2020.04.042_b0095","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1093\/clinids\/9.Supplement_5.S512","article-title":"Characterization of nontoxic monophosphoryl lipid A","volume":"9","author":"Johnson","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.042_b0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.04.042_b0105","series-title":"Innovation in Vaccinology: from design, through to delivery and testing","first-page":"205","article-title":"TLR agonists as vaccine adjuvants","author":"Tomai","year":"2012"},{"key":"10.1016\/j.vaccine.2020.04.042_b0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0021-9673(97)00041-1","article-title":"Analysis of a monophosphoryl lipid A immunostimulant preparation from Salmonella minnesota R595 by high-performance liquid chromatography","volume":"767","author":"Hagen","year":"1997","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2020.04.042_b0115","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0960-894X(99)00374-1","article-title":"Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs)","volume":"9","author":"Johnson","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.vaccine.2020.04.042_b0120","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1128\/IAI.73.5.3044-3052.2005","article-title":"Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge","volume":"73","author":"Cluff","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.04.042_b0125","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1586\/14760584.6.5.773","article-title":"E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant","volume":"6","author":"Ishizaka","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.04.042_b0130","doi-asserted-by":"crossref","first-page":"31982","DOI":"10.1074\/jbc.M109.046383","article-title":"Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A","volume":"284","author":"Cekic","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2020.04.042_b0135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/21645515.2016.1242540","article-title":"Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease","volume":"13","author":"Seid","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.04.042_b0140","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s11095-009-9859-5","article-title":"MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020)","volume":"26","author":"Baudner","year":"2009","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2020.04.042_b0145","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/jpet.300.2.655","article-title":"A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity","volume":"300","author":"Hawkins","year":"2002","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.vaccine.2020.04.042_b0150","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1128\/CVI.00153-07","article-title":"Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome","volume":"14","author":"Morefield","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0155","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4161\/hv.19229","article-title":"MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine","volume":"8","author":"Singh","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.04.042_b0160","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/erv.12.85","article-title":"Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects","volume":"11","author":"Dumonteil","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.04.042_b0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpharm.2015.03.028","article-title":"Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion","volume":"486","author":"Haensler","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2020.04.042_b0170","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1080\/21645515.2016.1168958","article-title":"Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis","volume":"12","author":"Visan","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.04.042_b0175","doi-asserted-by":"crossref","first-page":"e00876","DOI":"10.1128\/IAI.00876-17","article-title":"Vaccine-linked chemotherapy improves benznidazole efficacy for acute chagas disease","volume":"86","author":"Jones","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.04.042_b0180","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/glia.23132","article-title":"E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord","volume":"65","author":"Church","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.vaccine.2020.04.042_b0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ajad.12867","article-title":"Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant","volume":"28","author":"Arora","year":"2019","journal-title":"Am J Addict"},{"key":"10.1016\/j.vaccine.2020.04.042_b0190","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1086\/367990","article-title":"Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia","volume":"187","author":"Lynn","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.042_b0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/CVI.00738-13","article-title":"Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain","volume":"21","author":"Richard","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0200","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00574-16","article-title":"Monophosphoryl lipid A enhances efficacy of a Francisella tularensis LVS-catanionic nanoparticle subunit vaccine against F. tularensis Schu S4 challenge by augmenting both humoral and cellular immunity","volume":"24","author":"Richard","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0205","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1021\/bi00860a011","article-title":"Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235","volume":"6","author":"McIntire","year":"1967","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2020.04.042_b0210","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.1016\/S0021-9258(18)33836-5","article-title":"Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium","volume":"257","author":"Qureshi","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2020.04.042_b0215","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1128\/iai.61.6.2325-2333.1993","article-title":"Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl LipidA","volume":"61","author":"Henricson","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.04.042_b0220","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4049\/jimmunol.170.1.508","article-title":"Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR \u201chomotolerance\u201d versus \u201cheterotolerance\u201d on NF-kappa B signaling pathway components","volume":"170","author":"Dobrovolskaia","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0225","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.181.6.4159","article-title":"Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism","volume":"181","author":"Shirey","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0230","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1126\/science.aaf3036","article-title":"An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells","volume":"352","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.04.042_b0235","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41590-018-0243-7","article-title":"Autocrine-paracrine prostaglandin E2 signaling restricts TLR4 internalization and TRIF signaling","volume":"19","author":"Perkins","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0240","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.4049\/jimmunol.176.11.6888","article-title":"Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity","volume":"176","author":"Cole","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0245","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2020.04.042_b0250","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3369","article-title":"Quantitation of TLR4 internalization in response to LPS in thioglycollate elicited peritoneal mouse macrophages by flow cytometry","volume":"9","author":"Richard","year":"2019","journal-title":"Bio Protoc"},{"key":"10.1016\/j.vaccine.2020.04.042_b0255","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nchembio.2287","article-title":"The pharmacological regulation of cellular mitophagy","volume":"13","author":"Georgakopoulos","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0260","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1016\/j.vaccine.2018.05.101","article-title":"A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model","volume":"36","author":"Gregg","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.042_b0265","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cell.2011.09.051","article-title":"CD14 controls the LPS-induced endocytosis of Toll-like receptor 4","volume":"147","author":"Zanoni","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2020.04.042_b0270","article-title":"INTERFEROME v2. 0: an updated database of annotated interferon-regulated genes. 41 (database issue): D1040\u2013D1046 ed","author":"Rusinova","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2020.04.042_b0275","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbrc.2004.12.184","article-title":"Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll\/IL-1 domain containing adaptor inducing IFN-beta","volume":"328","author":"Hirotani","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2020.04.042_b0280","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/eji.200324714","article-title":"Identification of a TLR4- and TRIF-dependent activation program of dendritic cells","volume":"34","author":"Weighardt","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0285","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1128\/IAI.01681-05","article-title":"Organ-specific role of MyD88 for gene regulation during polymicrobial peritonitis","volume":"74","author":"Weighardt","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.04.042_b0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jre.12185","article-title":"Aging and contribution of MyD88 and TRIF to expression of TLR pathway-associated genes following stimulation with Porphyromonas gingivalis","volume":"50","author":"Shaik-Dasthagirisaheb","year":"2015","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.vaccine.2020.04.042_b0295","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nm1008","article-title":"Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways","volume":"10","author":"Bjorkbacka","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2020.04.042_b0300","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1152\/physiolgenomics.00128.2004","article-title":"The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades","volume":"19","author":"Bjorkbacka","year":"2004","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.vaccine.2020.04.042_b0305","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nature07924","article-title":"Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay","volume":"458","author":"Matsushita","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.04.042_b0310","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.110.961193","article-title":"High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide","volume":"122","author":"Suzuki","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.vaccine.2020.04.042_b0315","doi-asserted-by":"crossref","first-page":"31119","DOI":"10.1074\/jbc.M604958200","article-title":"Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide","volume":"281","author":"Thomas","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2020.04.042_b0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"Coler","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.04.042_b0325","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4049\/jimmunol.1003554","article-title":"Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists","volume":"189","author":"Polumuri","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0330","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cellsig.2017.12.002","article-title":"AKT1 distinctively suppresses MyD88-depenedent and TRIF-dependent Toll-like receptor signaling in a kinase activity-independent manner","volume":"43","author":"Zenke","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.vaccine.2020.04.042_b0335","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.4049\/jimmunol.1402183","article-title":"Phosphatase PTPN4 preferentially inhibits TRIF-dependent TLR4 pathway by dephosphorylating TRAM","volume":"194","author":"Huai","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0340","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fimmu.2018.00002","article-title":"Mycobacterial phenolic glycolipids selectively disable TRIF-dependent TLR4 signaling in macrophages","volume":"9","author":"Oldenburg","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0345","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2013.09.045","article-title":"Suppression of TRIF-dependent signaling pathway of toll-like receptors by (E)-1-(2-(2-nitrovinyl)phenyl)pyrrolidine","volume":"721","author":"Gu","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0350","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.4049\/jimmunol.164.10.5352","article-title":"Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors","volume":"164","author":"Genin","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0355","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.3390\/ijms16046902","article-title":"Anti-inflammatory effect of Streptochlorin via TRIF-dependent signaling pathways in cellular and mouse models","volume":"16","author":"Shim","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2020.04.042_b0360","doi-asserted-by":"crossref","unstructured":"Chi X, Li Y, Qiu X. V(D)J Recombination, Somatic Hypermutation and class switch recombination of immunoglobulins: mechanism and regulation. Immunology; 2020.","DOI":"10.1111\/imm.13176"},{"key":"10.1016\/j.vaccine.2020.04.042_b0365","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/CVI.00235-12","article-title":"Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines","volume":"19","author":"Fox","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0370","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1016\/j.vaccine.2013.09.069","article-title":"TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses","volume":"31","author":"Fox","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.04.042_b0375","doi-asserted-by":"crossref","first-page":"B14","DOI":"10.1016\/j.vaccine.2015.01.088","article-title":"New generation adjuvants\u2013from empiricism to rational design","volume":"33","author":"O'Hagan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.042_b0380","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1016\/j.vaccine.2009.07.081","article-title":"Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion","volume":"27","author":"Baldwin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.042_b0385","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0390","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.4049\/jimmunol.0803616","article-title":"Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF","volume":"182","author":"McAleer","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0395","doi-asserted-by":"crossref","first-page":"10413","DOI":"10.1128\/JVI.00928-10","article-title":"TLR4 ligands augment antigen-specific CD8+ T lymphocyte responses elicited by a viral vaccine vector","volume":"84","author":"Rhee","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0400","doi-asserted-by":"crossref","first-page":"ra13","DOI":"10.1126\/scisignal.2001963","article-title":"Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist","volume":"5","author":"Bowen","year":"2012","journal-title":"Sci Signaling"},{"key":"10.1016\/j.vaccine.2020.04.042_b0405","doi-asserted-by":"crossref","first-page":"13994","DOI":"10.1073\/pnas.1510760112","article-title":"Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation","volume":"112","author":"Hu","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.04.042_b0410","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ni1010","article-title":"Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways","volume":"4","author":"Hoebe","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2020.04.042_b0415","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20090247","article-title":"Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant","volume":"206","author":"Longhi","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.04.042_b0420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood-2012-02-413831","article-title":"TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in mice","volume":"121","author":"Pihlgren","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2020.04.042_b0425","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0264-410X(02)00737-5","article-title":"Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice","volume":"21","author":"Przetak","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:31Z","timestamp":1759401811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20305363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":85,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X20305363"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissociation of TRIF bias and adjuvanticity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}